Clinical Efficacy of Immune Checkpoint Inhibitors in Patients With Advanced Malignant Peritoneal Mesothelioma
Kanwal Raghav, Suyu Liu, Michael J. Overman, Ajaykumar C. Morani, Anneleis Willette, Keith F. Fournier, Gauri R. Varadhachary
Abstract
dedicated trials and larger cohorts to define biomarkers of response or resistance, early referral to clinical trials, and novel combinatorial strategies to enhance responses and outcomes for patients with MPeM.
Topics & Concepts
Peritoneal mesotheliomaMedicineMesotheliomaOncologyInternal medicineCohortImmune checkpointImmune systemImmunotherapyImmunologyPathologyCancerOccupational and environmental lung diseasesPancreatic and Hepatic Oncology ResearchMedical Imaging and Pathology Studies